Literature DB >> 23548612

Ceramide 1-phosphate induces macrophage chemoattractant protein-1 release: involvement in ceramide 1-phosphate-stimulated cell migration.

Lide Arana1, Marta Ordoñez, Alberto Ouro, Io-Guané Rivera, Patricia Gangoiti, Miguel Trueba, Antonio Gomez-Muñoz.   

Abstract

The bioactive sphingolipid ceramide 1-phosphate (C1P) is implicated in inflammatory responses and was recently shown to promote cell migration. However, the mechanisms involved in these actions are poorly described. Using J774A.1 macrophages, we have now discovered a new biological activity of C1P: stimulation of monocyte chemoattractant protein-1 (MCP-1) release. This novel effect of C1P was pertussis toxin (PTX) sensitive, suggesting the intervention of Gi protein-coupled receptors. Treatment of the macrophages with C1P caused activation of the phosphatidylinositol 3-kinase (PI3K)/Akt, mitogen-activated protein kinase kinase (MEK)/extracellularly regulated kinases (ERK), and p38 pathways. Inhibition of these kinases using selective inhibitors or specific siRNA blocked the stimulation of MCP-1 release by C1P. C1P stimulated nuclear factor-κB activity, and blockade of this transcription factor also resulted in complete inhibition of MCP-1 release. Also, C1P stimulated MCP-1 release and cell migration in human THP-1 monocytes and 3T3-L1 preadipocytes. A key observation was that sequestration of MCP-1 with a neutralizing antibody or treatment with MCP-1 siRNA abolished C1P-stimulated cell migration. Also, inhibition of the pathways involved in C1P-stimulated MCP-1 release completely blocked the stimulation of cell migration by C1P. It can be concluded that C1P promotes MCP-1 release in different cell types and that this chemokine is a major mediator of C1P-stimulated cell migration. The PI3K/Akt, MEK/ERK, and p38 pathways are important downstream effectors in this action.

Entities:  

Keywords:  ceramide 1-phosphate; macrophage migration; monocyte chemoattractant protein-1 release; sphingosine 1-phosphate

Mesh:

Substances:

Year:  2013        PMID: 23548612     DOI: 10.1152/ajpendo.00480.2012

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  27 in total

1.  Exogenous ceramide-1-phosphate (C1P) and phospho-ceramide analogue-1 (PCERA-1) regulate key macrophage activities via distinct receptors.

Authors:  Sebastián Katz; Orna Ernst; Dorit Avni; Muhammad Athamna; Amir Philosoph; Lide Arana; Alberto Ouro; L Alexis Hoeferlin; Michael M Meijler; Charles E Chalfant; Antonio Gómez-Muñoz; Tsaffrir Zor
Journal:  Immunol Lett       Date:  2015-12-03       Impact factor: 3.685

2.  An endoplasmic reticulum stress-initiated sphingolipid metabolite, ceramide-1-phosphate, regulates epithelial innate immunity by stimulating β-defensin production.

Authors:  Young-Il Kim; Kyungho Park; Jong Youl Kim; Ho Seong Seo; Kyong-Oh Shin; Yong-Moon Lee; Walter M Holleran; Peter M Elias; Yoshikazu Uchida
Journal:  Mol Cell Biol       Date:  2014-10-13       Impact factor: 4.272

3.  Regulation of the amount of ceramide-1-phosphate synthesized in differentiated human podocytes.

Authors:  Shamroop Kumar Mallela; Alla Mitrofanova; Sandra Merscher; Alessia Fornoni
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2019-09-02       Impact factor: 4.698

4.  Acid Ceramidase Deficiency is characterized by a unique plasma cytokine and ceramide profile that is altered by therapy.

Authors:  Shaalee Dworski; Ping Lu; Aneal Khan; Bruno Maranda; John J Mitchell; Rossella Parini; Maja Di Rocco; Boris Hugle; Makoto Yoshimitsu; Bo Magnusson; Balahan Makay; Nur Arslan; Norberto Guelbert; Karoline Ehlert; Andrea Jarisch; Janet Gardner-Medwin; Rawane Dagher; Maria Teresa Terreri; Charles Marques Lorenco; Lilianna Barillas-Arias; Pranoot Tanpaiboon; Alexander Solyom; James S Norris; Xingxuan He; Edward H Schuchman; Thierry Levade; Jeffrey A Medin
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-12-01       Impact factor: 5.187

Review 5.  Sphingolipids in spinal cord injury.

Authors:  Zachary B Jones; Yi Ren
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2016-08-05

Review 6.  Nuclear lipid mediators: Role of nuclear sphingolipids and sphingosine-1-phosphate signaling in epigenetic regulation of inflammation and gene expression.

Authors:  Panfeng Fu; David L Ebenezer; Alison W Ha; Vidyani Suryadevara; Anantha Harijith; Viswanathan Natarajan
Journal:  J Cell Biochem       Date:  2018-05-08       Impact factor: 4.429

7.  Substance P induces inflammatory responses involving NF-κB in genetically diabetic mice skin fibroblasts co-cultured with macrophages.

Authors:  Tao Ni; Yushu Liu; Yinbo Peng; Ming Li; Yong Fang; Min Yao
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

8.  Neuroprotective effect of water-dispersible hesperetin in retinal ischemia reperfusion injury.

Authors:  Akito Shimouchi; Harumasa Yokota; Shinji Ono; Chiemi Matsumoto; Toshihiro Tamai; Hiroko Takumi; Subbadra P Narayanan; Shoji Kimura; Hiroya Kobayashi; Ruth B Caldwell; Taiji Nagaoka; Akitoshi Yoshida
Journal:  Jpn J Ophthalmol       Date:  2015-09-25       Impact factor: 2.447

9.  C1P Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Preventing NF-κB Activation in Neutrophils.

Authors:  Kristin Baudiß; Rodolfo de Paula Vieira; Sanja Cicko; Korcan Ayata; Madelon Hossfeld; Nicolas Ehrat; Antonio Gómez-Muñoz; Holger K Eltzschig; Marco Idzko
Journal:  J Immunol       Date:  2016-01-22       Impact factor: 5.422

10.  The role of sphingosine-1 phosphate and ceramide-1 phosphate in trafficking of normal stem cells and cancer cells.

Authors:  Mariusz Z Ratajczak; Malwina Suszynska; Sylwia Borkowska; Janina Ratajczak; Gabriela Schneider
Journal:  Expert Opin Ther Targets       Date:  2013-11-04       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.